期刊文献+

接受连续肾脏替代治疗的危重患者中抗菌药物的剂量选择 被引量:13

Antibacterial dose recommendations for critically ill patients receiving continuous renal replacement therapy
原文传递
导出
摘要 在接受连续肾脏替代治疗(CRRT)的危重患者中,抗菌药物剂量的选择是个复杂的问题,剂量选择不合理会产生药物的毒性作用或直接导致治疗失败和细菌耐药。一般而言,表观分布容积决定初始剂量,总清除率决定维持剂量。药物表观分布容积在急性肾损伤或危重患者中可发生变化。CRRT患者对药物的清除率取决于其模式、剂量以及滤过膜的筛分系数或饱和系数,二者数值主要取决于药物的蛋白结合率。本文综述了接受CRRT危重患者使用抗菌药物的药动学和药效学特点和影响因素,并提出CRRT患者使用抗菌药物的剂量建议,为临床合理用药提供参考。 Antibacterial doses for critically ill patients receiving continuous renal replacement therapy(CRRT) are complicated,and failure to correctly choose a dose may result in either drug toxicity or treatment failure,and development of antibiotic resistance.In general,the initial dose depends on the volume of distribution,and maintenance doses depend on clearance.The volume of distribution of some antibacterials is altered by critical illness or acute kidney injure,or both.Clearance of drugs in CRRT depends on the dose and mode of CRRT,and the sieving or saturation coefficient of the drug.Both sieving and saturation coefficient relate to the plasma protein binding.
出处 《中国新药杂志》 CAS CSCD 北大核心 2010年第23期2142-2146,2180,共6页 Chinese Journal of New Drugs
关键词 抗菌药物 药物剂量 药动学 药效学 连续肾脏替代治疗 antibacterial agents drug dosing pharmacokinetics pharmacodynamics continuous renal replacement therapy
  • 相关文献

参考文献22

  • 1RUSSELL JA. Managcment of sepsis[J]. N Engl J Med, 2006, 355(16): 1699 -1713.
  • 2GRAZIANI G, BORDONE G, BELLATO V, et al. Role of the kidney in plasma cytokine removal in sepsis syndrome: a pilot study[J]. J Nephrol, 2006,19(2):176-182.
  • 3ROBERT JA, KRUGER P, PATERSON DL, et al. Antibiotic resisitance-what's dosing got to do with it? [J]. Crit Care Med, 2008,36 ( 8 ) :2433 - 2440.
  • 4RAHMAN TM, TREACHER D. Management of acute renal failure on the intensive care unit[J]. Clin Med, 2002, 2(2): 108 -113.
  • 5SCHENTAG JJ, GILLILAND KK, PALADINO JA. What have we learned from pharmacokinetie and pharmacodynamic theories? [J]. Clin Infect Dis, 2001, 32(Suppl1):S39-S46.
  • 6LI AMMY, GOMERSALL CD, CHOI G, et al. A systematic review of antibiotic dosing regimens for septic patients receiving continuous renal replacement therapy: do current studies supply sufficient data? [ J ]. J Antimicrob Chemother, 2009, 64 (5) : 929 -937.
  • 7HEINTA BH, MATZKE GR, DAGER WE. Antimicrobial dosing concepls and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis [ J ]. Pharmacotherapy, 2009,29 ( 5 ) : 562 - 577.
  • 8CHOI G, GOMERSALL CD, TIAN Q, et al. Principle of antibacterial dosing in continuous renal replacement therapy[J]. Crit Care Med, 2009,37 ( 7 ) : 2268 - 2282.
  • 9CHRISTERSSON BA, NILSSON-EHLE M, HUTCHINSON M, et al. Pharmacokinetics of meropenem in subjects with various degrees of renal impairment [ J ]. Antimicrob Agents Chemother, 1992,36(7) :1532 - 1537.
  • 10PEA F, VIALE P, PAVAN F, et al. Pharmacokinetic considerations for antimicrobial therapy in patients receiving eontinuous renal replacement therapy [ J ]. Clin Pharmacokinet, 2007, 46 (12) :997 - 1038.

同被引文献164

引证文献13

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部